Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $18.48 Analyst target: $35.40 Upside: 91.56%
Nuvectis Pharma, Inc., a biopharmaceutical company, is focused on the development of targeted small molecule therapies for the treatment of cancer. The company is headquartered in Fort Lee, New Jersey.
See the full interactive analysis & chart →Informational only — not investment advice.